2019
DOI: 10.1016/j.biopha.2018.10.082
|View full text |Cite
|
Sign up to set email alerts
|

Preeclampsia: A close look at renal dysfunction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0
5

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 81 publications
(43 citation statements)
references
References 109 publications
0
38
0
5
Order By: Relevance
“…The venous congestion and reduced arterial perfusion can lead to renal, placental and fetal ischemia [34]. In the clinical stage of PE, renal dysfunction is mostly present with reduced clearance, albuminuria and oliguria [35]. The observation that the prevalence of PE is higher in severely obese women and in multiple pregnancies, together with the increase in the frequency of PE towards the end of gestation, suggests that increased IAP is part of its pathophysiologic process [3,[36][37][38][39].…”
Section: Increase In Iap During Pregnancy Might Induce Venous Congestmentioning
confidence: 99%
“…The venous congestion and reduced arterial perfusion can lead to renal, placental and fetal ischemia [34]. In the clinical stage of PE, renal dysfunction is mostly present with reduced clearance, albuminuria and oliguria [35]. The observation that the prevalence of PE is higher in severely obese women and in multiple pregnancies, together with the increase in the frequency of PE towards the end of gestation, suggests that increased IAP is part of its pathophysiologic process [3,[36][37][38][39].…”
Section: Increase In Iap During Pregnancy Might Induce Venous Congestmentioning
confidence: 99%
“…However, there has been no study on infants' neurological development focused on PE with maternal renal dysfunction. PE is related to renal dysfunction owing to deficiency in podocyte-specific VEGF ( 47 ). Placental hypoxic condition in PE cases causes elevated levels of fms-like tyrosine kinase 1 (sFlt-1) and a soluble receptor of VEGF.…”
Section: Discussionmentioning
confidence: 99%
“…sFlt-1 produced by M1s may have acted to neutralize VEGF and KTP-ELP-VEGF, further explaining the relative insensitivity of M1s to VEGF. Elevated sFlt-1 levels have been shown to be detrimental in the kidney, causing glomerular injury and damage to the filtration barrier [40-42]. Given the extensive infiltration of M1 macrophages in chronic renal injury [26], it is possible that secretion of sFlt-1 by M1s may drive the suppression of VEGF signaling and subsequent MV injury in RVD.…”
Section: Discussionmentioning
confidence: 99%